{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T03:35:35Z","timestamp":1768275335347,"version":"3.49.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"am","delay-in-days":362,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.hrthm.2023.11.007","type":"journal-article","created":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T19:06:07Z","timestamp":1699729567000},"page":"313-320","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Type 3 long QT syndrome: Is the effectiveness of treatment with beta-blockers population-specific?"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2392-3759","authenticated-orcid":false,"given":"Alexis","family":"Hermida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Baptiste","family":"Gourraud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Denjoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"Fressart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Kyndt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Maltret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diala","family":"Khraiche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didier","family":"Klug","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Mabo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Sacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Maury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Winum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Defaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gael","family":"Clerici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Babuty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yedid","family":"Elbez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Morgat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elodie","family":"Surget","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Messali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"De Jode","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aur\u00e9lien","family":"Cl\u00e9del","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damien","family":"Minois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Maison-Blanche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrien","family":"Bloch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Leenhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Probst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8123-4842","authenticated-orcid":false,"given":"Fabrice","family":"Extramiana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2023.11.007_bib1","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1161\/CIRCULATIONAHA.113.003985","article-title":"Long QT syndrome","volume":"129","author":"Abrams","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2023.11.007_bib2","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1056\/NEJM199810013391404","article-title":"Influence of the genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group","volume":"339","author":"Zareba","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2023.11.007_bib3","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1001\/jama.296.10.1249","article-title":"Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome","volume":"296","author":"Hobbs","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2023.11.007_bib4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1161\/01.CIR.103.1.89","article-title":"Genotype-phenotype correlation in the long-QT syndrome","volume":"103","author":"Schwartz","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2023.11.007_bib5","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1056\/NEJMoa022147","article-title":"Risk stratification in the long-QT syndrome","volume":"348","author":"Priori","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2023.11.007_bib6","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0735-1097(99)00582-3","article-title":"Differential effects of beta-adrenergic agonists and antagonists in LQT1, LQT2 and LQT3 models of the long QT syndrome","volume":"35","author":"Shimizu","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2023.11.007_bib7","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/cvr\/cvq029","article-title":"Autonomic modulation and antiarrhythmic therapy in a model of long QT syndrome type 3","volume":"87","author":"Fabritz","year":"2010","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.hrthm.2023.11.007_bib8","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1161\/01.CIR.101.6.616","article-title":"Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome","volume":"101","author":"Moss","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2023.11.007_bib9","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1001\/jama.292.11.1341","article-title":"Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers","volume":"292","author":"Priori","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2023.11.007_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185680","article-title":"Effectiveness of beta-blockers depending on the genotype of congenital long-QT syndrome: a meta-analysis","volume":"12","author":"Ahn","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.hrthm.2023.11.007_bib11","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1161\/CIRCULATIONAHA.116.021823","article-title":"Clinical aspects of type 3 long-QT syndrome: an international multicenter study","volume":"134","author":"Wilde","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2023.11.007_bib12","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/jamacardio.2023.1951","article-title":"Association between syncope trigger type and risk of subsequent life-threatening events in patients with long QT syndrome","volume":"8","author":"Younis","year":"2023","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.hrthm.2023.11.007_bib13","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1161\/CIRCULATIONAHA.110.950147","article-title":"Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them?: data from the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry","volume":"122","author":"Schwartz","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2023.11.007_bib14","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.jacc.2018.01.078","article-title":"Interplay between genetic substrate, QTc duration, and arrhythmia risk in patients with long QT syndrome","volume":"71","author":"Mazzanti","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2023.11.007_bib15","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003379","article-title":"Further insights in the most common SCN5A mutation causing overlapping phenotype of long QT syndrome, Brugada syndrome, and conduction defect","volume":"5","author":"Veltmann","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hrthm.2023.11.007_bib16","article-title":"Clinical course, risk stratification and response to beta-blockers in patients with long QT syndrome type 3. Abstract 20515","volume":"136","author":"Maragna","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2023.11.007_bib17","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2023.11.007_bib18","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/europace\/euw214","article-title":"Systematic ajmaline challenge in patients with long QT 3 syndrome caused by the most common mutation: a multicentre study","volume":"19","author":"Hohmann","year":"2017","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2023.11.007_bib19","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1161\/CIRCULATIONAHA.107.707877","article-title":"Gating properties of SCN5A mutations and the response to mexiletine in long-QT syndrome type 3 patients","volume":"116","author":"Ruan","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2023.11.007_bib20","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/CIRCRESAHA.118.314050","article-title":"Predicting patient response to the antiarrhythmic mexiletine based on genetic variation","volume":"124","author":"Zhu","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.hrthm.2023.11.007_bib21","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1161\/01.CIR.101.14.1698","article-title":"Effects of flecainide in patients with new SCN5A mutation","volume":"101","author":"Benhorin","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2023.11.007_bib22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1542-474X.2005.00077.x","article-title":"Safety and efficacy of flecainide in subjects with long QT-3 syndrome (DeltaKPQ mutation): a randomized, double-blind, placebo-controlled clinical trial","volume":"10","author":"Moss","year":"2005","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1016\/j.hrthm.2023.11.007_bib23","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/europace\/euw439","article-title":"Long-term flecainide therapy in type 3 long QT syndrome","volume":"20","author":"Chorin","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2023.11.007_bib24","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jacc.2015.12.033","article-title":"Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3","volume":"67","author":"Mazzanti","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2023.11.007_bib25","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.116.004370","article-title":"Ranolazine for congenital long-QT syndrome type III: experimental and long-term clinical data","volume":"9","author":"Chorin","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2023.11.007_bib26","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1111\/j.1540-8167.2008.01246.x","article-title":"Ranolazine shortens repolarization in patients with sustained inward sodium current due to type-3 long-QT syndrome","volume":"19","author":"Moss","year":"2008","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2023.11.007_bib27","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1161\/CIRCULATIONAHA.108.772533","article-title":"High efficacy of beta-blockers in long-QT syndrome type 1: contribution of noncompliance and QT-prolonging drugs to the occurrence of beta-blocker treatment \u201cfailures.\u201d","volume":"119","author":"Vincent","year":"2009","journal-title":"Circulation"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527123029107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527123029107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:00:11Z","timestamp":1761548411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527123029107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1547527123029107"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2023.11.007","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type 3 long QT syndrome: Is the effectiveness of treatment with beta-blockers population-specific?","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2023.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Heart Rhythm Society. All rights reserved.","name":"copyright","label":"Copyright"}]}}